Michael Anthony Quinn Insider Profile
4 Followers
Michael Anthony Quinn, Director at Amplia Therapeutics, holds 0.00 shares in Amplia Therapeutics (Ticker: INNMF). Most recently, Michael Anthony Quinn Sold 2,011,604 shares of Amplia Therapeutics on Jun 30, 2017 for an estimated value of $109.63K.
Michael Anthony Quinn's Trading History
| INNMFAmplia Therapeutics | Jun 30, 2017 | Director | Informative Sell | 109.63K | $0.00 | |||||||||||||||||||||||||||||||||||||||||||
INNMF Insider Shares: 0.00 (0.00%)
| ||||||||||||||||||||||||||||||||||||||||||||||||
You May Also Like
Michael Anthony Quinn insider profile FAQ
What is the percentage of profitable transactions made by Michael Anthony Quinn?
The percentage of profitable transactions made by Michael Anthony Quinn is 50%.
What is the average return per transaction made by Michael Anthony Quinn?
The average return per transaction made by Michael Anthony Quinn is 45.70%.
What stocks does Michael Anthony Quinn hold?
Michael Anthony Quinn holds: INNMF stocks.
What was Michael Anthony Quinn’s latest transaction?
Michael Anthony Quinn’s latest transaction was an Informative Sell of $109.63K.
What was Michael Anthony Quinn's most profitable transaction?
Michael Anthony Quinn’s most profitable transaction was an Informative Buy of INNMF stock on April 19, 2016. The return on the trade was 301.20%.
What is Michael Anthony Quinn's role in Amplia Therapeutics?
Michael Anthony Quinn's role in Amplia Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
